跳至主要内容
临床试验/NCT06049758
NCT06049758尚未招募不适用

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy In Right Cancer Colon Patients: A Randomized Controlled Trial

General Committee of Teaching Hospitals and Institutes, Egypt1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年1月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Number of lymph node harvesting in the final specimen

研究概览

简要总结

Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years

详细描述

Surgical Technique and Preparation Enoxaparin sodium 40 mg subcutaneous injection will be administered 12 hours before the operation, and Levofloxacin 500 mg intravenous injection will be administered 1 hour before the operation.

Procedures will be performed under general anesthesia.

Group A:

Location of trocars and surgeons:

The patient will be placed in the Trendelenburg position and tilt to the left, with the surgeon standing between the patient's legs, the camera operator standing on the patient's left side, the assistant standing on the right of the camera operator, and the scrub nurse standing on the patient's right side.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)
  • Diagnosed by CT entero-colonography
  • Diagnosed by colonoscopy
  • Diagnosed by biopsy.

排除标准

  • Emergency surgery (obstruction, perforation with generalized peritonitis),
  • Metastatic tumor diagnosed
  • ASA score of IV or higher
  • Need for more than one surgical procedure
  • Conversion to open surgery

研究组 & 干预措施

Laparoscopic hemicolectomy with Complete Mesocolic Excision

Active Comparator

Patients will have laparoscopic hemicolectomy with Complete Mesocolic Excision, D3 lymph node dissection.

干预措施: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention) (Procedure)

Laparoscopic hemicolectomy with Complete Mesocolic Excision

Active Comparator

Patients will have laparoscopic hemicolectomy with Complete Mesocolic Excision, D3 lymph node dissection.

干预措施: Enoxaparin 40 Mg/0.4 mL Injectable Solution (Drug)

Laparoscopic hemicolectomy with Complete Mesocolic Excision

Active Comparator

Patients will have laparoscopic hemicolectomy with Complete Mesocolic Excision, D3 lymph node dissection.

干预措施: Levofloxacin 500mg (Drug)

Conventional laparoscopic right hemicolectomy

Active Comparator

Patients will have conventional laparoscopic right hemicolectomy with D2 lymph node dissection.

干预措施: Enoxaparin 40 Mg/0.4 mL Injectable Solution (Drug)

Conventional laparoscopic right hemicolectomy

Active Comparator

Patients will have conventional laparoscopic right hemicolectomy with D2 lymph node dissection.

干预措施: Levofloxacin 500mg (Drug)

Conventional laparoscopic right hemicolectomy

Active Comparator

Patients will have conventional laparoscopic right hemicolectomy with D2 lymph node dissection.

干预措施: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional) (Procedure)

结局指标

主要结局

Number of lymph node harvesting in the final specimen

时间窗: 6 months post-operative

incidence of lymph node

Number of post-operative ICU admission

时间窗: immediately after the intervention/procedure/surgery

Incidence of ICU admission after surgery

Number of blood units needed

时间窗: during the intervention/procedure/surgery

Guided by hemoglobine levels during surgery

Number of postoperative outcomes

时间窗: 6 months post-operative

the medical condition from the patient

Number of anastomotic leakage

时间窗: Within 30 days post-operative

incidence of anastomotic leakage

次要结局

  • Overall survival time after 5-years(5 years post-operative)

研究者

发起方
General Committee of Teaching Hospitals and Institutes, Egypt
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Mohamed Hany Ashour

Principal Investigator

General Committee of Teaching Hospitals and Institutes, Egypt

研究点 (1)

Loading locations...

相似试验